Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic beta-cell apoptosis - Kapodistria, K; Tsilibary, E P; Kotsopoulou, E (J Cell Mol Med, 2018)